Forecast
Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional
Food and Drug Administration
AI Overview
Development of physiologically-based pharmacokinetic models to predict how long-acting injectable drugs and implants release medication in the body over time. This research aims to create better tools for understanding drug absorption from these sustained-release formulations, potentially reducing the need for extensive clinical testing.
This summary is AI-generated from the official solicitation.
Key Details
Agency
Food and Drug Administration
Funding Amount
—
Release Date
November 21, 2023
Due Date
—
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial